Skip to main content
Clinical Trials/CTRI/2024/02/062254
CTRI/2024/02/062254
Not yet recruiting
Phase 4

A comparative evaluation of the efficacy of continuous infusion and intermittent bolus of 0.2% Ropivacaine in Ultrasound guided Adductor canal block for postoperative analgesia in Total knee replacement surgeries- A prospective randomised double blinded study. - Nil

Tata Motors Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Sponsor
Tata Motors Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Tata Motors Hospital

Eligibility Criteria

Inclusion Criteria

  • Patient’s informed consent
  • Age of patient\- 55\-75years
  • Patients undergoing Total Knee Replacement Surgery
  • ASA grade I,II

Exclusion Criteria

  • Patient’s refusal
  • Any bleeding disorder or coagulopathies
  • ASA grade III,IV
  • Allergy/contraindication to any drugs used in study
  • Chronic opioid user
  • Any neurologic deficit
  • Failed neuraxial anaesthesia
  • Infection/inflammation at site of injection

Outcomes

Primary Outcomes

Not specified

Similar Trials